Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1982 Apr;36(1):198–201. doi: 10.1128/iai.36.1.198-201.1982

Some characteristics of a urease-negative, temperature- sensitive strain of Bordetella bronchiseptica as a live, attenuated vaccine.

T Shimizu, H Ishikawa
PMCID: PMC351203  PMID: 7076293

Abstract

Strain ts-S34 of Bordetella bronchiseptica was treated jointly with two mutagens, nitrosoguanidine and UV irradiation, and a urease-negative (u-), temperature-sensitive (ts) mutant strain indistinguishable from Alcaligenes faecalis in its biochemical characteristics was isolated. However, the mutant isolated was a phase III organism. By repeating selection of smaller, hemolytic colonies observed among phase III colonies after prolonged incubation, a phase I organism, strain ts-S34.u-, was isolated. The u- and ts properties of the mutant strain were hereditarily stable, and heat-labile toxin production was very low. Growth in KCN broth and on Simmons citrate agar was reduced. Agglutinability of the strain against anti-S1 and anti-ts-S34.u- hyperimmune sera was as high (X20,480) as that of wild-type strain S1. The live ts-S34.u- strain vaccination protected guinea pigs from challenge exposure with 15,000 X the 50% lethal dose of virulent strain S1 of B. bronchiseptica. In these studies, it appeared that the ts-S34.u- strain has favorable properties, including a useful hereditary marker and low heat-labile toxin production, for use as a live attenuated vaccine.

Full text

PDF
198

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hanada M., Shimoda K., Tomita S., Nakase Y., Nishiyama Y. Production of lesions similar to naturally occurring swine atrophic rhinitis by cell-free sonicated extract of Bordetella bronchiseptica. Nihon Juigaku Zasshi. 1979 Feb;41(1):1–8. doi: 10.1292/jvms1939.41.1. [DOI] [PubMed] [Google Scholar]
  2. Harris D. L., Switzer W. P. Nasal and tracheal resistance of swine against reinfection by Bordetella bronchiseptica. Am J Vet Res. 1969 Jul;30(7):1161–1166. [PubMed] [Google Scholar]
  3. Shimizu T., Nakagawa M., Shibata S., Suzuki K. Atrophic rhinitis produced by intranasal inoculation of Bordetella bronchiseptica in hysterectomy produced colostrum-deprived pigs. Cornell Vet. 1971 Oct;61(4):696–705. [PubMed] [Google Scholar]
  4. Shimizu T. Prophylaxis of Bordetella bronchiseptica infection in guinea pigs by intranasal vaccination with live strain ts-S34. Infect Immun. 1978 Nov;22(2):318–321. doi: 10.1128/iai.22.2.318-321.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES